Diffusion Pharmaceuticals Inc. [NASDAQ: DFFN] price surged by 21.00 percent to reach at $0.13. The company report on May 14, 2021 that DFFN: Encouraging Data for TSC in COVID-19 Patients….
By David Bautz, PhD.
A sum of 4134588 shares traded at recent session while its average daily volume was at 3.50M shares. Diffusion Pharmaceuticals Inc. shares reached a high of $0.78 and dropped to a low of $0.615 until finishing in the latest session at $0.75.
Guru’s Opinion on Diffusion Pharmaceuticals Inc. [DFFN]:
H.C. Wainwright have made an estimate for Diffusion Pharmaceuticals Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on November 17, 2020. While these analysts kept the previous recommendation, H.C. Wainwright raised their target price to Buy. The new note on the price target was released on March 21, 2018, representing the official price target for Diffusion Pharmaceuticals Inc. stock.
The Average True Range (ATR) for Diffusion Pharmaceuticals Inc. is set at 0.06 The Price to Book ratio for the last quarter was 1.17, with the Price to Cash per share for the same quarter was set at 0.48.
DFFN Stock Performance Analysis:
Diffusion Pharmaceuticals Inc. [DFFN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 10.68. With this latest performance, DFFN shares gained by 13.41% in over the last four-week period, additionally plugging by 5.44% over the last 6 months – not to mention a drop of -32.57% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for DFFN stock in for the last two-week period is set at 51.49, with the RSI for the last a single of trading hit 57.22, and the three-weeks RSI is set at 48.34 for Diffusion Pharmaceuticals Inc. [DFFN]. The present Moving Average for the last 50 days of trading for this stock 0.8244, while it was recorded at 0.6494 for the last single week of trading, and 0.9171 for the last 200 days.
Insight into Diffusion Pharmaceuticals Inc. Fundamentals:
Diffusion Pharmaceuticals Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 22.40 and a Current Ratio set at 22.40.
DFFN Stock EPS
With the latest financial reports released by the company, Diffusion Pharmaceuticals Inc. posted -0.06/share EPS, while the average EPS was predicted by analysts to be reported at -0.05/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -20.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for DFFN.
Diffusion Pharmaceuticals Inc. [DFFN] Insider Position Details
There are presently around $7 million, or 8.50% of DFFN stock, in the hands of institutional investors. The top three institutional holders of DFFN stocks are: VANGUARD GROUP INC with ownership of 4,120,872, which is approximately 947.955% of the company’s market cap and around 0.13% of the total institutional ownership; BLACKROCK INC., holding 2,044,449 shares of the stock with an approximate value of $1.27 million in DFFN stocks shares; and RENAISSANCE TECHNOLOGIES LLC, currently with $1.13 million in DFFN stock with ownership of nearly -35.58% of the company’s market capitalization.
17 institutional holders increased their position in Diffusion Pharmaceuticals Inc. [NASDAQ:DFFN] by around 6,119,422 shares. Additionally, 12 investors decreased positions by around 1,479,047 shares, while 3 investors held positions by with 2,178,843 shares. The mentioned changes placed institutional holdings at 9,777,312 shares, according to the latest SEC report filing. DFFN stock had 8 new institutional investments in for a total of 462,957 shares, while 10 institutional investors sold positions of 450,147 shares during the same period.